Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glaucoma | 7 | 2021 | 241 | 0.750 |
Why?
|
| Diabetic Retinopathy | 3 | 2025 | 200 | 0.740 |
Why?
|
| Tomography, Optical Coherence | 10 | 2025 | 257 | 0.690 |
Why?
|
| Choroid | 3 | 2022 | 78 | 0.600 |
Why?
|
| Glaucoma, Angle-Closure | 4 | 2019 | 21 | 0.470 |
Why?
|
| Optic Disk | 4 | 2020 | 52 | 0.440 |
Why?
|
| Visual Fields | 4 | 2021 | 115 | 0.390 |
Why?
|
| Glaucoma, Open-Angle | 4 | 2014 | 104 | 0.360 |
Why?
|
| Graves Ophthalmopathy | 2 | 2022 | 13 | 0.350 |
Why?
|
| Intraocular Pressure | 6 | 2020 | 315 | 0.320 |
Why?
|
| India | 7 | 2021 | 208 | 0.310 |
Why?
|
| Retinal Vessels | 2 | 2025 | 75 | 0.260 |
Why?
|
| Capillaries | 1 | 2025 | 125 | 0.220 |
Why?
|
| Nerve Fibers | 2 | 2020 | 100 | 0.200 |
Why?
|
| Retinal Ganglion Cells | 2 | 2020 | 116 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 2526 | 0.170 |
Why?
|
| Optometrists | 1 | 2021 | 8 | 0.170 |
Why?
|
| Eye | 1 | 2021 | 113 | 0.170 |
Why?
|
| Macular Edema | 1 | 2021 | 46 | 0.170 |
Why?
|
| Ophthalmology | 2 | 2019 | 105 | 0.160 |
Why?
|
| Visual Acuity | 3 | 2019 | 443 | 0.160 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2019 | 5 | 0.150 |
Why?
|
| Cornea | 1 | 2020 | 154 | 0.150 |
Why?
|
| Fluorescein Angiography | 4 | 2025 | 175 | 0.150 |
Why?
|
| Central Serous Chorioretinopathy | 1 | 2019 | 4 | 0.150 |
Why?
|
| Blindness | 1 | 2019 | 48 | 0.150 |
Why?
|
| Steroids | 1 | 2019 | 163 | 0.140 |
Why?
|
| Organ Size | 2 | 2015 | 478 | 0.140 |
Why?
|
| Gonioscopy | 4 | 2019 | 11 | 0.120 |
Why?
|
| Trabeculectomy | 2 | 2013 | 74 | 0.120 |
Why?
|
| Middle Aged | 13 | 2025 | 34438 | 0.120 |
Why?
|
| Retinal Telangiectasis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Adult | 13 | 2025 | 39181 | 0.110 |
Why?
|
| Ectopia Lentis | 1 | 2014 | 1 | 0.110 |
Why?
|
| Iris | 1 | 2014 | 22 | 0.110 |
Why?
|
| Cross-Sectional Studies | 6 | 2022 | 5636 | 0.110 |
Why?
|
| Macula Lutea | 1 | 2014 | 22 | 0.100 |
Why?
|
| Corneal Diseases | 1 | 2014 | 44 | 0.100 |
Why?
|
| Aged | 8 | 2025 | 24576 | 0.100 |
Why?
|
| Epidemiologic Research Design | 1 | 2013 | 29 | 0.100 |
Why?
|
| Tonometry, Ocular | 4 | 2014 | 103 | 0.100 |
Why?
|
| Epidemiologic Methods | 1 | 2013 | 96 | 0.100 |
Why?
|
| Antihypertensive Agents | 2 | 2014 | 508 | 0.100 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2012 | 50 | 0.090 |
Why?
|
| Vision Disorders | 1 | 2013 | 157 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 1074 | 0.090 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 47 | 0.090 |
Why?
|
| Phacoemulsification | 1 | 2013 | 120 | 0.090 |
Why?
|
| Male | 14 | 2025 | 69789 | 0.080 |
Why?
|
| Prevalence | 4 | 2019 | 2772 | 0.080 |
Why?
|
| Telemedicine | 1 | 2019 | 891 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2022 | 7739 | 0.080 |
Why?
|
| Cataract | 1 | 2013 | 223 | 0.080 |
Why?
|
| Female | 14 | 2025 | 75522 | 0.080 |
Why?
|
| Humans | 18 | 2025 | 141197 | 0.070 |
Why?
|
| Rural Population | 1 | 2013 | 604 | 0.070 |
Why?
|
| Age Distribution | 2 | 2019 | 395 | 0.070 |
Why?
|
| Molecular Biology | 2 | 2019 | 60 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2020 | 16273 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2015 | 2269 | 0.060 |
Why?
|
| Young Adult | 5 | 2022 | 13673 | 0.050 |
Why?
|
| Visual Field Tests | 2 | 2013 | 32 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 7856 | 0.040 |
Why?
|
| Axial Length, Eye | 1 | 2020 | 16 | 0.040 |
Why?
|
| Capacity Building | 1 | 2021 | 62 | 0.040 |
Why?
|
| Photography | 1 | 2021 | 115 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 214 | 0.040 |
Why?
|
| Anterior Chamber | 1 | 2019 | 26 | 0.040 |
Why?
|
| Fundus Oculi | 1 | 2019 | 86 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 379 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 2059 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3588 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 2086 | 0.030 |
Why?
|
| Adolescent | 3 | 2019 | 22007 | 0.030 |
Why?
|
| Vitrectomy | 1 | 2014 | 78 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 2014 | 71 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 3292 | 0.020 |
Why?
|
| Academies and Institutes | 1 | 2013 | 55 | 0.020 |
Why?
|
| Scanning Laser Polarimetry | 1 | 2012 | 2 | 0.020 |
Why?
|
| Anthropometry | 1 | 2013 | 208 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 2014 | 133 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 1310 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 324 | 0.020 |
Why?
|
| Developing Countries | 1 | 2013 | 317 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5200 | 0.020 |
Why?
|
| Risk Factors | 2 | 2013 | 10438 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1973 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1820 | 0.020 |
Why?
|
| Child | 2 | 2019 | 22310 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 2793 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3348 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 1763 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 2892 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2014 | 6275 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 9818 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 11120 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 11457 | 0.010 |
Why?
|